Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer.

Zhao J, Lawless MW.

Cytokine. 2013 Dec;64(3):626-37. doi: 10.1016/j.cyto.2013.09.009. Epub 2013 Oct 11. Review.

PMID:
24120848
2.

Visceral adiposity in gastrointestinal and hepatic carcinogenesis.

Vongsuvanh R, George J, Qiao L, van der Poorten D.

Cancer Lett. 2013 Mar 1;330(1):1-10. doi: 10.1016/j.canlet.2012.11.038. Epub 2012 Nov 29. Review.

PMID:
23201597
3.

Visceral obesity, metabolic syndrome, insulin resistance and cancer.

Doyle SL, Donohoe CL, Lysaght J, Reynolds JV.

Proc Nutr Soc. 2012 Feb;71(1):181-9. doi: 10.1017/S002966511100320X. Epub 2011 Nov 3.

PMID:
22051112
4.
5.

Obesity and Liver Cancer.

Aleksandrova K, Stelmach-Mardas M, Schlesinger S.

Recent Results Cancer Res. 2016;208:177-198. Review.

PMID:
27909908
6.

The double role of epicardial adipose tissue as pro- and anti-inflammatory organ.

Iacobellis G, Barbaro G.

Horm Metab Res. 2008 Jul;40(7):442-5. doi: 10.1055/s-2008-1062724. Epub 2008 Mar 13.

PMID:
18401833
7.

Obesity-driven inflammation and colorectal cancer.

Vazzana N, Riondino S, Toto V, Guadagni F, Roselli M, Davi G, Ferroni P.

Curr Med Chem. 2012;19(34):5837-53. Review.

PMID:
23033947
8.

Pathophysiology of human visceral obesity: an update.

Tchernof A, Després JP.

Physiol Rev. 2013 Jan;93(1):359-404. doi: 10.1152/physrev.00033.2011. Review.

PMID:
23303913
9.

Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.

Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang L, Wang T, Hong S, Guo S, She ZG, Zhang XD, Li H.

Am J Physiol Endocrinol Metab. 2013 Aug 15;305(4):E485-95. doi: 10.1152/ajpendo.00505.2012. Epub 2013 May 21.

PMID:
23695216
10.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

11.

Obesity-associated mechanisms of hepatocarcinogenesis.

Karagozian R, Derdák Z, Baffy G.

Metabolism. 2014 May;63(5):607-17. doi: 10.1016/j.metabol.2014.01.011. Epub 2014 Feb 5. Review.

PMID:
24629562
12.

Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.

Park HS, Park JY, Yu R.

Diabetes Res Clin Pract. 2005 Jul;69(1):29-35. Epub 2004 Dec 30.

PMID:
15955385
13.

Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer.

Modesitt SC, Hsu JY, Chowbina SR, Lawrence RT, Hoehn KL.

Int J Gynecol Cancer. 2012 Jun;22(5):732-41. doi: 10.1097/IGC.0b013e3182510496.

PMID:
22635025
15.

What causes the insulin resistance underlying obesity?

Hardy OT, Czech MP, Corvera S.

Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):81-7. doi: 10.1097/MED.0b013e3283514e13. Review.

16.

Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.

Samaras K, Botelho NK, Chisholm DJ, Lord RV.

Obesity (Silver Spring). 2010 May;18(5):884-9. doi: 10.1038/oby.2009.443. Epub 2009 Dec 17.

17.

The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity.

Kantartzis K, Rittig K, Balletshofer B, Machann J, Schick F, Porubska K, Fritsche A, Häring HU, Stefan N.

Clin Chem. 2006 Oct;52(10):1934-42. Epub 2006 Aug 17.

18.

Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.

Lee JW, Im JA, Lee HR, Shim JY, Youn BS, Lee DC.

Obesity (Silver Spring). 2007 Sep;15(9):2225-32.

19.

Biological specificity of visceral adipose tissue and therapeutic intervention.

Perrini S, Leonardini A, Laviola L, Giorgino F.

Arch Physiol Biochem. 2008 Oct;114(4):277-86. doi: 10.1080/13813450802334752 . Review.

PMID:
18946788
20.

Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.

Odrowaz-Sypniewska G.

Adv Med Sci. 2007;52:246-50. Review.

PMID:
18217426

Supplemental Content

Support Center